Effect of Pioglitazone and Cetuximab on Colon Cancer Stem-like Cell (CCSLCs) Properties.
Nasim AlamdarShirin FarivarKaveh BaghaeiAmir Ali HamidiehHossein SoltaninejadHamid Asadzadeh AghdaeiMohammadreza ZaliZohreh SaltanatpourPublished in: Current stem cell research & therapy (2024)
Pio and Cet could inhibit EMT and reduce CSC markers in the EMT induced/CSC enriched cell line. We expect that focus on finding EMT/CSC-targeting agents like these drugs can be helpful for cancer treatment.